Publications scientifiques LYSA

Lysa 2022_LYSA_From Stem Cell Transplantation to CAR-T Therapy in Relapse-Refractory Diffuse Large B-Cell Lymphoma

Christian Gisselbrecht, Eric Van Den Neste

doi.org/10.18103/mra.v10i8.3014 En savoir plus

Lysa 2022_LYSA_Do we have to exclude all relapsed diffuse large B-cell lymphoma patients not in complete remission from autologous stem cell transplant?

Christian Gisselbrecht, David Sibon

doi: 10.1111/bjh.18468 En savoir plus

Lysa 2022_LYSA_Outcomes of patients with aggressive B-Cell lymphoma after failure of anti-CD19 CAR T-Cell Therapy. A DESCAR-T analysis

Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François-Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, René-Olivier Casanovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean-Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont

doi: 10.1182/blood.2022016945. En savoir plus

Calym HemSys_Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase

Lise-Marie Mollard, Aurélie Chauveau, Françoise Boyer-Perrard, Nathalie Douet-Guilbert, Roch Houot, Isabelle Quintin-Roué, Marie-Anne Couturier, Anaig Dagorne, Mohamed Malou, Ronan Le Calloch, Odile Luycx, Sylvain Thepot, Mathilde Hunault, Gaelle Guillerm, Christian Berthou, Valérie Ugo, Éric Lippert & Jean-Christophe Ianotto

Leukemia & Lymphoma, 59:12, 2812-2820, DOI: 10.1080/10428194.2018.1441408 En savoir plus

Calym HemSys_IGHV segment utilization in immunoglobulin gene rearrangement differentiates patients with anti-myelin-associated glycoprotein neuropathy from others immunoglobulin M-gammopathies

Jean-Sebastien Allain, Florian Thonier, Morgane Pihan, Marie-Laure Boulland, Sophie de Guibert, Vincent Launay, Anne-Violaine Doncker, Michel Ganard, Amyra Aliouat, Céline Pangault, Roch Houot, Marie De Tayrac, Thierry Lamy, Mikael Roussel, Thierry Fest, Olivier Decaux, Cedric Pastoret

Haematologica 2018;103(5):e207-e210; https://doi.org/10.3324/haematol.2017.177444. En savoir plus

Calym HemSys_Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome

L. Alix, A. Néel, B. Cador, A. Smail, J. Serratrice, F. Closs-Prophette, P. Jego, A. Devillers & O. Decaux

Autoimmunity, 52:7-8, 264-271, DOI: 10.1080/08916934.2019.1680649 En savoir plus

Calym HemSys_Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)

Durot, E., Tomowiak, C., Michallet, A.-S., Dupuis, J., Hivert, B., Leprêtre, S., Toussaint, E., Godet, S., Merabet, F., Van Den Neste, E., Ivanoff, S., Roussel, X., Zini, J.-M., Regny, C., Lemal, R., Sutton, L., Perrot, A., Le Dû, K., Kanagaratnam, L., Morel, P., Leblond, V. and Delmer, A.

Br J Haematol, 179: 439-448. https://doi.org/10.1111/bjh.14881 En savoir plus

HemSys_Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

Reboursiere E., Bras F., Herbaux C., Gyan E., Clavert A., Morschhauser F., Malak S., Sibon D., Broussais F., Braun T., Fornecker L., Garidi R., Tricot S., et al

Oncotarget. 2016; 7: 85573-85583. Retrieved from https://www.oncotarget.com/article/10764/text/ En savoir plus

Calym HemSys_Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life

Norwood, J., Pastoret, C., Luycx, O., Le Coz, M.-F., Moreau, P., Trebouet, A., Niault, M., Launay, V., Allangba, O., Bareau, B., Doncker, V., Grulois, I., Jacomy, D., Le Dû, K., Henry, C., Le Pabic, E., Boulland, M.-L., Fest, T., Lamy, T. and Escoffre-Barbe, M.

Am J Hematol, 93: E329-E331. https://doi.org/10.1002/ajh.25217 En savoir plus

Calym HemSys_Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement

Mercier M, Orvain C, Drieu La Rochelle L, Marchand T, Nunes Gomes C, Giltat A, Paillassa J, Clavert A, Farhi J, Rousselet M-C, Gyan E, Houot R, Moles-Moreau M-P, Hunault-Berger M.

Cancers 2021, 13(12), 2945; https://doi.org/10.3390/cancers13122945 En savoir plus

Calym HemSys_Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Sophie Langner-Lemercier, Caroline Houillier, Carole Soussain, Hervé Ghesquières, Olivier Chinot, Luc Taillandier, Pierre Soubeyran, Thierry Lamy, Franck Morschhauser, Alexandra Benouaich-Amiel, Guido Ahle, Marie-Pierre Moles-Moreau, Cécile Moluçon-Chabrot, Pascal Bourquard, Ghandi Damaj, Fabrice Jardin, Delphine Larrieu, Emmanuel Gyan, Remy Gressin, Arnaud Jaccard, Sylvain Choquet, Annie Brion, Olivier Casasnovas, Philippe Colin, Oumedaly Reman, Adrian Tempescul, Jean-Pierre Marolleau, Michel Fabbro, Florian Naudet, Khê Hoang-Xuan, Roch Houot

Neuro-Oncology, Volume 18, Issue 9, September 2016, Pages 1297–1303, https://doi.org/10.1093/neuonc/now033 En savoir plus

Calym HemSys_Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study

Isabelle Fleury, Sandy Amorim, Nicolas Mounier, Bertrand Coiffier, Jehan Dupuis, Hervè Tilly, Mohamed A. Mazari, Lauriane Filliatre, Josette Brière, Pauline Brice, Eric de Kerviler & Catherine Thieblemont

Leukemia & Lymphoma, 56:7, 2025-2031, DOI: 10.3109/10428194.2014.977884 En savoir plus

Lysa 2022_LYSA_A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Pierre Sesques, Guillaume Manson, Guillaume Cartron, David Beauvais, Louise Roulin, François Xavier Gros, Marie Thérèse Rubio, Pierre Bories, Jacques Olivier Bay, Cristina Castilla Llorente, Sylvain Choquet, René-Olivier Casasnovas, Mohamad Mohty, Stéphanie Guidez, Magalie Joris, Michaël Loschi, Sylvain Carras, Julie Abraham, Adrien Chauchet, Laurianne Drieu La Rochelle, Bénédicte Deau-Fischer, Olivier Hermine, Thomas Gastinne, Jean Jacques Tudesq, Elodie Gat, Florence Broussais, Catherine Thieblemont, Roch Houot & Franck Morschhauser

doi: 10.1038/s41591-022-01969-y. En savoir plus

Lysa 2022_LYSA_PET-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T-cells

Jean Galtier, Laetitia Vercellino, Loic Chartier, Pierre Olivier, Claire Tabouret-Viaud, Charles Mesguich, Roberta Di Blasi, Amandine Durand, Léo Raffy, François-Xavier Gros, Isabelle Madelaine, Veronique Meignin, Miryam Mebarki, Marie-Thérèse Rubio, Pierre Feugier, Olivier Casasnovas, Michel Meignan, Catherine Thieblemont

doi: 10.3324/haematol.2021.280550. En savoir plus

Lysa 2022_LYSA_Interpretation of 2-[ 18 F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors

Manson G, Lemchukwu AC, Mokrane FZ, Lopci E, Aide N, Vercellino L, Houot R, Dercle L.

Eur Radiol . 2022 Sep;32(9):6536-6544. En savoir plus

Lysa 2022_LYSA_Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

Nicolae A, Bouilly J, Lara D, Fataccioli V, Lemonnier F, Drieux F, Parrens M, Robe C, Poullot E, Bisig B, Bossard C, Letourneau A, Missiaglia E, Bonnet C, Szablewski V, Traverse-Glehen A, Delfau-Larue MH, de Leval L, Gaulard P

Mod Pathol . 2022 Aug;35(8):1126-1136. En savoir plus

Lysa 2022_LYSA_Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)

Manson G, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Regny C, Bouabdallah K, Chauchet A, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Dercle L, Brice P, Houot R; Lymphoma Study Association (LYSA).

Br J Haematol . 2022 Jul;198(1):203-206. En savoir plus

Lysa 2022_LYSA_Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study

Amira Marouf, Anne-Ségolène Cottereau, Salim Kanoun, Paul Deschamps, Michel Meignan, Patricia Franchi, David Sibon, Clara Antoine, Thomas Gastine, Cecile Borel, Mohammad Hammoud, Guillaume Sicard, Romane Gille, Doriane Cavalieri, Aspasia Stamatoullas, Lauriane Filliatre-Clement, Julien Lazarovici, Adrien Chauchet, Luc-Matthieu Fornecker, Sandy Amorin, Mathieu Rocquet, Nicolae Raus, Barbara urroni, Marie-Thérèse Rubio, Didier Bouscary, Pilippe Quittet, René-Olivier Casanovas, Pauline Brice, Hervé Guesquieres, Jerome Tamburini, Benedicte Deau

Haematologica . 2022 Jul 1;107(7):1681-1686. En savoir plus

Lysa 2022_LYSA_Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with Mantle Cell lymphoma, a LYSA retrospective study

Domitille Costes-Tertrais, Thomas Hueso, Thomas Gastinne, Catherine Thieblemont, Lucie Oberic, Krimo Bouabdallah, Sylvain Garciaz, Emmanuelle Tchernonog, Caroline Dartigeas, vincent ribrag, Patrick Fogarty, René-Olivier Casasnovas, Roch Houot, Caroline Delette, Sandra Malak, Luc-Matthieu Fornecker, Remy Gressin, Gandhi Damaj, and Steven Le Gouill

Bone Marrow Transplant . 2022 Apr;57(4):627-632. En savoir plus

Lysa 2022_LYSA_The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Baptiste Eluard, Stéphanie Nuan-Aliman, Nathalie Faumont, Davi Collares, Didier Bordereaux, Aurélie Montagne, Isabelle Martins, Nicolas Cagnard, Martial Caly, Oussama Taoui, Leonardo Lordello, Jacqueline Lehmann-Che, Bruno Tesson, Jose-Angel Angel Martinez-Climent, Christiane Copie-Bergman, Corinne Haioun, Herve Tilly, Benjamin Bonsang, Anne Vincent-Salomon, Jean-Philippe Jais, Fabrice Jardin, Karen Leroy, Maria Chiara Maiuri, Guido Kroemer, Thierry Jo Molina, Jean Feuillard, Véronique Baud

Blood . 2022 Jan 20;139(3):384-398. En savoir plus

Lysa 2022_LYSA_Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study

Aspasia Stamatoullas, Hervé Ghesquières, Pierre Feugier, Marc André, Fabien Le Bras, Anne-Claire Gac, Cécile Borel, Thomas Gastinne, Philippe Quittet, Franck Morschhauser, Vincent Ribrag, Stephanie Guidez, Emmanuelle Nicolas-Virelizier, Alina Berriolo-Riedinger, Thierry Vander Borght, Véronique Edeline, Pauline Brice

doi: 10.1080/10428194.2022.2107204. En savoir plus

Lysa 2022_LYSA_Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

Franck Morschhauser, Loretta Nastoupil, Pierre Feugier, Jean-Marc Schiano de Colella, Hervé Tilly, Maria Lia Palomba, Emmanuel Bachy, Christophe Fruchart, Edward N Libby, Rene-Olivier Casasnovas, Ian W Flinn, Corinne Haioun, Hervé Maisonneuve, Loic Ysebaert, Nancy L Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Steven Le Gouill, Nicolas Daguindau, Stéphanie Guidez, Gian Matteo Pica, Alejandro Martín García-Sancho, Armondo López-Guillermo, Jean-François Larouche, Kiyoshi Ando, Maria Gomes da Silva, Marc André, Wu Kalung, Laurie H Sehn, Koji Izutsu, Guillaume Cartron, Argyrios Gkasiamis, Russell Crowe, Luc Xerri, Nathan H Fowler, Gilles Salles

J Clin Oncol . 2022 Aug 10;JCO2200843. En savoir plus

Lysa 2022_LYSA_Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial

Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, Rene-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Krimo Bouabdallah, Pierre Feugier, Lena Specht, Lysiane Molina, Mohamed Touati, Cecile Borel, Aspasia Stamatoullas, Emmanuelle Nicolas-Virelizier, Laurent Pascal, Pieternella Lugtenburg, Nicola Di Renzo, Thierry Vander Borght, Alexandra Traverse-Glehen, Peggy Dartigues, Martin Hutchings, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, for the LYSA-FIL-EORTC Intergroup

doi: 10.1200/JCO.21.01281. En savoir plus

Lysa 2022_LYSA_High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: TMTV is a useful risk factor to stratify patients at baseline

Rossi C, André M, Dupuis J, Morschhauser F, Joly B, Lazarovici J, Ghesquières H, Stamatoullas A, Nicolas-Virelizier E, Feugier P, Gac AC, Moatti H, Fornecker LM, Deau B, Joubert C, Fortpied C, Raemaekers J, Federico M, Kanoun S, Meignan M, Traverse-Glehen A, Cottereau AS, Casasnova RO

doi: 10.3324/haematol.2021.280004 En savoir plus

Lysa 2022_LYSA_Outcomes of elderly diffuse large B-cell lymphoma patients treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

Vincent Camus, Aurelien Belot, Lucie Obéric, David Sibon, Herve Ghesquieres, Catherine Thieblemont, Christophe Fruchart, Olivier Casasnovas, Jean-Marie Michot, Thierry Molina, Andre Bosly, Clementine Joubert, Corinne Haioun, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Herve Tilly

10.1182/bloodadvances.2022007609. En savoir plus

Lysa 2022_LYSA_Oncogenetic landscape of lymphomagenesis in coeliac disease

Sascha Cording, Ludovic Lhermitte, Georgia Malamut, Sofia Berrabah, Amélie Trinquand, Nicolas Guegan, Patrick Villarese, Sophie Kaltenbach, Bertrand Meresse, Sherine Khater, Michael Dussiot, Marc Bras, Morgane Cheminant, Bruno Tesson, Christine Bole-Feysot, Julie Bruneau, Thierry Jo Molina, David Sibon, Elizabeth Macintyre, Olivier Hermine, Christophe Cellier, Vahid Asnafi, Nadine Cerf-Bensussan, CELAC network

Gut . 2022 Mar;71(3):497-508. En savoir plus

Lysa 2022_LYSA_PET-driven strategy in advanced Hodgkin lymphoma: prolonged follow-up of the AHL2011 Phase III LYSA study

René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquieres, Aspasia Stamatoullas, Jehan Dupuis, Anne-Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Franck Morschhauser, David Sibon, Christophe Bonnet, Alina Berriolo-Riedinger, Véronique Edeline, Marie Parrens, Diane Damotte, Diane Coso, Marc André, Michel Meignan, Cédric Rossi

J Clin Oncol . 2022 Apr 1;40(10):1091-1101. En savoir plus

Lysa 2022_LYSA_Lenalidomide-induced arthritis: A case report and review of literature and pharmacovigilance databases

Charlotte Icard, Pauline Mocquot, Jean-Claude Nogaro, Fabien Despas, Martin Gauthier

J Oncol Pharm Pract . 2022 Mar;28(2):453-456. En savoir plus

Lysa 2022_LYSA_Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials

Carla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, Eva Hoster, Howard Hochster, Wolfgang Hiddemann, Robert E Marcus, Eva K Kimby, Michael Herold, Catherine J Sebban, Emmanuel Gyan, Kenneth A Foon, Tina G Nielsen, Umberto Vitolo, Gilles Andre Salles, Qian Shi, Christopher R Flowers

Blood . 2022 Mar 17;139(11):1684-1693. En savoir plus

Lysa 2022_LYSA_A guide to ComBat harmonization of imaging biomarkers in multicenter studies

Fanny Orlhac, Jakoba J. Eertink, Anne-Ségolène Cottereau, Josée M. Zijlstra, Catherine Thieblemont, Michel Meignan, Ronald Boellaard, Irène Buvat

J Nucl Med . 2022 Feb;63(2):172-179. En savoir plus

Lysa 2022_LYSA_Deep Learning approach to automatize TMTV calculation regardless of segmentation methodology for main FDG avid lymphomas

Wendy Revailler, Anne-Ségolène Cottereau, Cédric Rossi, Rudy Noyelle, Thomas Trouillard, Franck Morschhauser, Rene-Olivier Casasnovas, Catherine Thieblemont, Steven Le Gouill, Marc P-E André, Hervé Ghesquières, Romain Ricci, Michel Meignan, Salim Kanoun

Diagnostics (Basel) . 2022 Feb 6;12(2):417. En savoir plus

Lysa 2022_LYSA_Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma

Roch Houot, Viola Poeschel, Bettina Altmann, Stephanie Angel, Lorenz Thurner, Thomas Illmer, Marc Andre, Martin Dreyling, Hervé Maisonneuve, Hervé Tilly, Stephanie Mayer, Olivier Casasnovas, Steven Le Gouill, Fritz Offner, Guillaume Cartron, Andrea Kerkhoff, Thomas Weber, Joerg Hoffmann, Marita Ziepert, Wolfram Klapper, Emmanuel Itti, Dirk Hellwig, Giorgi Natchkebia, Laurence de Leval, Andreas Rosenwald, Corinne Haioun, Laurent Dercle, Philippe Gaulard, Gerhard Held

Hemasphere . 2022 Jan 10;6(2):e672. En savoir plus

Lysa 2022_LYSA_Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study

Alexandra‑Cristina Paunescu, Christiane Copie Bergman, Sandra Malak, Steven Le Gouill, Vincent Ribrag, Krimo Bouabdallah, David Sibon, Gerhard Rumpold, Marie Preau, Nicolas Mounier, Corinne Haioun, Fabrice Jardin, Caroline Besson

Ann Hematol . 2022 Feb;101(2):317-332. En savoir plus

Lysa 2022_LYSA_Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group

Christophe Bonnet, Jehan Dupuis, Hervé Tilly, Thierry Lamy, Christophe Fruchart, Steven le Gouill, Catherine Thieblemont, Franck Morschhauser, Olivier Casasnovas, Krimo Bouabdallah, Hervé Ghesquieres, Eric Van Den Neste, Marc André, Guillaume Cartron, Gilles Salles

Cancers (Basel) 2022 Mar 30;14(7):1761. doi: 10.3390/cancers14071761. En savoir plus

Lysa 2022_LYSA_Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study

Virginie Nerich, Christophe Guyeux, Michel Henry-Amar, Raphaël Couturier, Catherine Thieblemont, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René-Olivier Casasnovas, Franck Morschhauser, Pierre Feugier, David Sibon, Loic Ysebaert, Emmanuelle Nicolas-Virelizier, Florence Broussais-Guillaumot, Gandhi L Damaj, Jean-Philippe Jais, Gilles Salles, Macha Woronoff-Lemsi, Nicolas Mounier

Cancer . 2022 Feb 1;128(3):519-528. doi: 10.1002/cncr.33938. En savoir plus

Lysa 2022_LYSA_Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

Emmanuel Bachy; Vincent Camus; Catherine Thieblemont; David Sibon; René-Olivier Casasnovas; Loïc Ysebaert; Gandhi Damaj; Stéphanie Guidez; Gian Matteo Pica; Won Seog Kim; Soon Thye Lim; Marc André; Alejandro Martín García-Sancho; Maria Jesus Penarrubia; Philipp B. Staber; Judith Trotman; Andreas Hüttmann; Vittorio Stefoni; Alessandro Re; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Michel Meignan; Ju Li; Franck Morschhauser; and Richard Delarue

J Clin Oncol . 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815. En savoir plus

Lysa 2022_LYSA_Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Hervé Tilly, Franck Morschhauser, Laurie H Sehn, Jonathan W Friedberg, Marek Trněný, Jeff P Sharman, Charles Herbaux, John M Burke, Matthew Matasar, Shinya Rai, Koji Izutsu, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan M Bergua-Burgués, Matthew C Cheung, Antonio Pinto, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta, Jyh-Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R Flowers, Gilles Salles

N Engl J Med . 2022 Jan 27;386(4):351-363. doi: 10.1056/NEJMoa2115304. En savoir plus

Lysa 2022_LYSA_Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study

René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquieres, Aspasia Stamatoullas, Jehan Dupuis, Anne-Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Franck Morschhauser, David Sibon, Christophe Bonnet, Alina Berriolo-Riedinger, Véronique Edeline, Marie Parrens, Diane Damotte, Diane Coso, Marc André, Michel Meignan, Cédric Rossi

J Clin Oncol 2022 Jan 6;JCO2101777. doi: 10.1200/JCO.21.01777 En savoir plus

Publications scientifiques LYSA

Publications 2022